Connelly Partners Launches Connelly Partners Health
Independent agency Connelly Partners (CP) announced Sept. 13 the launch of Connelly Partners Health (CP Health), a new dedicated health practice as part of the agency’s integrated offering.
About PR Newswire
This author has yet to write their bio.Meanwhile lets just say that we are proud PR Newswire contributed a whooping 1007 entries.
Entries by PR Newswire
Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity
Regeneron Pharmaceuticals Inc. and AstraZeneca today announced that the companies entered into a collaboration to research, develop and commercialize small molecule compounds directed against the GPR75 target with the potential to treat obesity and related co-morbidities.
closerlook wins bronze Cannes Lion for myasthenia gravis documentary series, “A Mystery to Me”
Digital-native agency closerlook won a bronze Pharma Lion for a docuseries developed with global immunology company argenx that depicts the experiences of people living with myasthenia gravis (MG), a rare and chronic neuromuscular autoimmune disease. The award win for “A Mystery to Me” was announced at the Cannes Lions International Festival of Creativity in France.
Doceree Bolsters Senior Leadership with Appointment of President, North America
Doceree Inc., the first global network of physician-only platforms for programmatic marketing, announced the appointment of Stephen Hoelper as the company’s president, North America.
Huntsworth’s MEDiSTRAVA acquires medical analytics firm MedEvoke
International healthcare and communications group Huntsworth announced the acquisition of U.S.-based medical analytics consultancy MedEvoke.
New life sciences company takes aim at obesity
A made-in-Canada life sciences company, Nimium Therapeutics, launched to develop novel therapies for patients with cardiometabolic diseases.
ObvioHealth Raises $31 Million, Adds Two Strategic Partners
ObvioHealth Raises $31 Million, Adds Two Strategic Partners to Bolster Capabilities and Drive Growth Globally NEW YORK, July 1, 2021 /PRNewswire/ — ObvioHealth, a global Virtual Research Organization (VRO), announces it has raised $31 million in its latest round of financing. The round was led by two new partners: Dedalus Group, an international healthcare IT and […]
Abbott’s Xience Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
Abbott’s Xience family of stents received U.S. Food and Drug Administration approval for one-month (as short as 28 days) dual anti-platelet therapy labeling for high bleeding risk patients in the United States.
PRECISIONscientia Announces Organizational Changes
PRECISIONscientia announced two strategic personnel changes to advance the Pennsylvania-based full-service medical communications agency’s growth plans, as well as its vision of achieving a new industry standard for medical communications.
Precision Medicine Group Significantly Expands Cell And Gene Therapy Expertise With Acquisition Of Project Farma
Precision Medicine Group acquired Project Farma, a patient-focused bioengineering services firm that supports life science innovators in the manufacturing and scale-up of advanced therapies.
